Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience
Objective: Lipoprotein(a) [Lp(a)] has been associated with Atherosclerotic Cardiovascular Disease (ASCVD). Approximately 20 % of the population has elevated Lp(a). Despite its well-recognized role in ASCVD, universal screening remains controversial. The aim of our study is to investigate laboratory...
Saved in:
Main Authors: | Matteo Manzato (Author), Jeffery W. Meeusen (Author), Leslie J. Donato (Author), Allan S. Jaffe (Author), Vlad C. Vasile (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
by: Xingdi Hu, et al.
Published: (2023) -
Sex differences in lipid and lipoprotein metabolism
by: Brian T. Palmisano, et al.
Published: (2018) -
A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects
by: K P Shiva Govindan, et al.
Published: (2015) -
Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity
by: Christin W. Waage, et al.
Published: (2022) -
Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes
by: Michelle D. Kelsey, et al.
Published: (2023)